spacer
home > pmps > winter 2019 > embracing spray drying strategies
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Embracing Spray Drying Strategies

Orally inhaled drug products have several therapeutic advantages over other dosage forms − most notably, a more direct delivery to the central nervous system. By their very nature, they avoid the first pass effect through the liver, for both regional as well as systemic delivery. This allows drug developers to formulate delivery strategies that reduce the dosage strength and limit the risk of adverse side effects. While pharmaceutical companies have long recognised the potential of inhalation products, many are starting to explore development techniques such as spray drying in more depth.

This article will outline the benefits of using respirable-engineered dry powder for inhalation products, as well as discussing how the new 505 (b) (2) application route for faster approval of new formulations that use existing APIs is a suitable pathway to getting these products to market quickly and efficiently.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
5
     

There are no comments in regards to this article.

spacer
Aditya R Das PhD, MBA is Director of Business Development at Recipharm and is focussed on inhalation drug product development and commercialisation for global clients. He is responsible for coordinating the interface between client needs and external services and capabilities to facilitate optimal product development and global registration. Aditya has over 25 years’ experience working in combination biopharmaceutical product development, including pulmonary, transdermal, intravenous, implanted, and oral drug delivery therapeutic strategies and is an inventor on eight issued patents. He has a PhD in chemical engineering, an MBA from the University of California, US, an MS degree in chemical engineering from Carnegie Mellon University, US, and a BS degree in chemical engineering from the University of New Hampshire, US.
spacer
Aditya R Das PhD, MBA
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

International biomed specialist appoints WHP to deliver key expansion project

New state of the art cleanroom facilities will enable a leading international gene and cell therapy company to expand its bioprocessing operations and manufacturing capabilities.
More info >>

White Papers

Successfully managing the unique demands of cell therapy supply chains

PCI Pharma Services

Cell therapy professionals joined a specialist webinar by industry experts from PCI Clinical Services and TrakCel, addressing the unique complexity of an autologous therapy supply chain. Hosted by European Pharmaceutical Manufacturer magazine, the webinar was delivered by Rachel Griffiths, Associate Director, Technical Services, PCI Clinincal Services, and Dr. Matthew Lakelin, Vice President, Scientific Affairs and Business Development, TrakCel . Here, we present the white paper from that webinar event.
More info >>

 
Industry Events

BioTrinity 2019

30 April - 1 May 2019, etc.venues 155 Bishopsgate, London EC2M 3YD

BioTrinity 2019 is taking place from the 30th April – 1stMay at etc.venues 155 Bishopsgatein London. Now in its 13th year, BioTrinity remains the leading Life Sciences Biopartnering and Investment conference in Europe, and generates unrivalled opportunities for life science companies, academics, investors, and major pharmaceutical players to come together to do deals and establish collaborations.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement